Economic evaluation of artesunate and three quinine regimens in the treatment of severe malaria in children at the Ebolowa Regional Hospital-Cameroon: a cost analysis

BACKGROUND: Severe malaria is a leading cause of morbidity and mortality in under-fives in sub-Saharan Africa. Recently quinine has been replaced by artesunate as the first-line drug in the treatment of severe malaria in Cameroon. Artesunate has been shown to be cost-effective in African children, b...

Descripción completa

Detalles Bibliográficos
Autores principales: Maka, Daniel Ethe, Chiabi, Andreas, Obadeyi, Bolaji, Mah, Evelyn, Nguefack, Séraphin, Nana, Pamela, Mbacham, Wilfred, Mbonda, Elie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5142138/
https://www.ncbi.nlm.nih.gov/pubmed/27923381
http://dx.doi.org/10.1186/s12936-016-1639-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5142138/
https://www.ncbi.nlm.nih.gov/pubmed/27923381
http://dx.doi.org/10.1186/s12936-016-1639-1

Ejemplares similares